The Brain Cancer Program, in partnership with the Center for Music and Medicine at Johns Hopkins, will study whether music therapy is feasible in newly diagnosed GBM patients undergoing standard care.
Glioblastoma (Newly Diagnosed)
Cognitive capacity to respond to surveys
Access to computer and web access
Ability to attend virtual music therapy sessions
Not planning to undergo standard of care radiation therapy and concurrent and adjuvant temozolomide.
A life expectancy of less than 6 months.
Concurrent use of any other standard or investigational agents (excepting tumor treating fields).
Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection or psychiatric illness/social situations that would limit adherence with study requirements.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Lead sponsor
Keep Punching Foundation
Collaborator